Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

NCT04011410 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Recurrent

Interventions

DRUG: Hydroxychloroquine Sulfate 200Mg Tab

Sponsor

Patrick Hensley